Tumor Tracking Systems Market Size Outlook , Demand, Competitive Analysis, Growth Factors, Forecast 2022-2031

The Tumor Tracking Systems market studied is anticipated to grow with a CAGR of nearly 4.9% during the forecast period.

Certain factors that are driving the market growth include increasing prevalence of tumor cancers and technological advancements. Globally, cancer is one of the leading causes of death. The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period.

The World Health Organization (WHO) estimates the rate of cancer number to increase to 70% over the next two decades. Additionally, the increased burden of several lifestyle disorders is also expected to drive the market, as biomarkers play a vital role in risk assessment, early diagnosis, and effective monitoring of treatment.

According to the WHO, Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Approximately 70% of deaths from cancer occur in low- and middle-income countries.

Get a PDF Sample for more detailed market insights: https://www.sdki.jp/sample-request-85991

As data is being generated aggressively in the healthcare sector, a few developing countries have surpassed the lack of data, and it is likely to become so in the remaining countries as well. This augmentation of data is expected to provide the basis for any national policy on cancer. In turn, this factor may possibly lead to an increase in the percentage of people opting for cancer treatment.

Key Market Trends

Prostate Cancer Holds Significant Share in the Global Tumor Tracking Systems Market

– Prostate cancer is the second-most common form of cancer that affects men, worldwide. As per the American Cancer Society, in 2018, the United States witnessed around 164,690 new cases of prostate cancer, causing over 26,430 deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. In order to tackle such challenges, extensive research in the field of diagnostics has been undertaken. The popular biomarker, Prostate Specific Antigen (PSA), was introduced in the late 1980s, and has guided prostate cancer diagnosis for over 20 years. The next generation of prostate cancer biomarkers has introduced new assays in serum and urine, which are expected to replace PSA. Moreover, with such a high prevalence rate of prostate cancer across the world, the demand for tumor tracking systems is sure to rise, in turn, leading to the growth of this segment in the years to come.

Tumor Tracking Systems Market Size Outlook , Demand, Competitive Analysis, Growth Factors, Forecast 2022-2031
Ibuprofen API Market Size Outlook , Demand, Competitive Analysis, Growth Factors, Key Players Forecast 2022-2031
Medical Protective Equipment Market Size Inclinations and Development Status Highlighted During Forecast Period 2022-2031
Intragastric Balloon Market Size Outlook – Rising Demand, Share, Trends, Growth, Opportunities and Top Key Forecast 2022-2031
Male Infertility Market Size Share, Analysis, Applications, Sale, Growth Insight, Trends, Leaders, Services and Forecast 2022-2031
Oxytocin Market Size: Global Trends, Share, Growth, Opportunity Forecast 2022-2031

Related Articles

Back to top button